Free tool

Rare disease stocks

We cover 34 companies grouped under the Rare disease theme. The median market value in the group is $3.55B. Across the group, the median move over the past trading day is +1.58%. 84% of the 32 with a 200-day average trade above it. Price change over the past year runs from +15.1% to +265.0% across the middle 80 percent of the group, with a median of +78.0%.

Other lists in this group

Table

34 of 268 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
CRNXCrinetics Pharmaceuticals, Inc.$9.00BMid cap+182.02%
IMVTImmunovant, Inc.$8.95BMid cap+192.14%
RYTMRhythm Pharmaceuticals, Inc.$7.78BMid cap+14.26%
SRRKScholar Rock Holding Corporation$7.09BMid cap+74.77%
ORKAOruka Therapeutics, Inc.$6.74BMid cap+601.72%
LQDALiquidia Corporation$6.31BMid cap+168.53%
KNSAKiniksa Pharmaceuticals International, plc$6.17BMid cap+142.74%
PTCTPTC Therapeutics, Inc. Common Stock$6.13BMid cap+49.03%
DNTHDianthus Therapeutics, Inc.$6.13BMid cap+378.90%
TVTXTravere Therapeutics, Inc.$6.06BMid cap+288.91%
MIRMMirum Pharmaceuticals, Inc.$5.98BMid cap+36.58%
GRFSGrifols, S.A.$5.44BMid cap−17.62%
DYNDyne Therapeutics, Inc.$4.92BMid cap+102.62%
EWTXEdgewise Therapeutics, Inc.$4.80BMid cap+209.16%
AMLXAmylyx Pharmaceuticals, Inc.$4.17BMid cap+340.71%
MANEVeradermics, Incorporated$4.11BMid cap+171.13%
CPRXCatalyst Pharmaceuticals Inc$3.85BMid cap+52.72%
CLDXCelldex Therapeutics, Inc.$3.24BMid cap+87.96%
IRONDisc Medicine, Inc.$3.16BMid cap+38.71%
ARQTArcutis Biotherapeutics, Inc.$3.12BMid cap+58.44%
VRDNViridian Therapeutics, Inc.$2.74BMid cap+30.21%
PHVSPharvaris N.V.$2.62BMid cap+57.76%
RAREUltragenyx Pharmaceutical Inc.$2.61BMid cap−9.60%
TRVITrevi Therapeutics, Inc.$2.56BMid cap+146.57%
VERAVera Therapeutics, Inc.$2.54BMid cap+65.32%
NKTRNektar Therapeutics$2.52BMid cap+176.20%
BCRXBioCryst Pharmaceuticals, Inc.$2.51BMid cap+17.16%
MLYSMineralys Therapeutics, Inc.$2.32BMid cap+78.70%
COAGHemab Therapeutics Holdings, Inc.$2.32BMid cap+46.03%
AUPHAurinia Pharmaceuticals Inc.$2.23BMid cap+38.03%
ZBIOZenas BioPharma, Inc.$2.20BMid cap+103.93%
STOKStoke Therapeutics, Inc.$2.16BMid cap+77.32%
ADMAADMA Biologics, Inc.$2.14BMid cap−42.86%
PVLAPalvella Therapeutics, Inc.$2.14BMid cap+195.71%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse